Company Overview of Bain Capital, LP
Bain Capital, LP is an investment holding company operating through its subsidiaries, Sankaty Advisors, LP; Brookside Capital Management, LLC; Bain Capital Ventures; Bain Capital Public Equity; Bain Capital Private Equity; and Absolute Return Capital, LLC. The firm was founded in 1984 and is based in Boston, Massachusetts with additional offices across the United States, Asia, and Europe.
200 Clarendon Street
John Hancock Tower
Boston, MA 02116
Founded in 1984
Key Executives for Bain Capital, LP
Co-Founder, Co-Chairman, and Managing Director
Managing Director, Chief Operating Officer, and Chief Financial Officer
Compensation as of Fiscal Year 2016.
Bain Capital, LP Key Developments
Bayer’s Dermatology Unit Sale Said to Attract Many Investors
Sep 20 16
Bayer AG (DB:BAYN) dermatology unit is attracting interest from a number of health-care and private equity firms as the German company seeks to raise cash for its $66 billion acquisition of Monsanto Co., according to people with knowledge of the matter. Teva Pharmaceutical Industries Ltd. (NYSE:BX), Perrigo Company plc (NYSE:PRGO) and Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) are among companies considering offers, said the people. Buyout firms including KKR & Co. L.P. (NYSE:KKR), Nordic Capital, Bain Capital, LP, The Blackstone Group L.P. (Nyse;BX) and Cinven Limited may also look at the asset, the people said. Initial offers are due in the coming weeks, the people said. The discussions are at an early stage and no final decisions have been made, they said. Bayer is working with JPMorgan Chase & Co. on the sale, which could fetch more than €1 billion ($1.1 billion), people familiar with the process said earlier this month.
PE Firms Reportedly Seeks MEDall Healthcare
Sep 20 16
Apax Partners LLp, Bain Capital, L.P, KKR & Co. L.P. (NYSE:KKR), Baring Private Equity Asia and The Carlyle Group LP (NasdaqGS:CG) are in initial talks to acquire 100% stake in MEDall Healthcare Pvt Ltd. Its top investor Peepul Capital LLC, which owns around 80% stake, and promoter Raju Venkataraman appointed Spark Capital to look for buyers that is expected to be valued at around $300 million, Economic mes reported citing three people with direct knowledge of the development. It is believed that the buyout funds have been approached by the bankers and the terms sheets will be submitted soon. Medall Managing Director Raju Venkataraman did not respond to calls and emails. Emails sent to spokespersons of Peepul Capital, Apax, Bain, Barings Asia, Carlyle and KKR, too, did not elicit any response as of press time.
Takata Reportedly Moves Forward With The Auction
Sep 20 16
Takata Corporation (TSE:7312) is moving forward with its auction. The Carlyle Group LP (NasdaqGS:CG), Daicel Corporation (TSE:4202), Bain Capital, LP KKR & Co. L.P. (NYSE:KKR) and Key Safety Systems, Inc. are the potential buyers for Takata. Carlyle Group is working with Key Safety Systems Inc. and Daicel Corp. is jointly bidding with Bain Capital. Bidders for Takata have been asked to submit their proposals by early this week, and Takata aims to shortlist two to three candidates by October. Some of the bidders are considering the possibility of some form of bankruptcy proceedings for Takata to mitigate the liabilities.
Similar Private Companies By Industry
Recent Private Companies Transactions